Editas Medicine, Inc.

11 Hurley Street

Cambridge, MA 02141

 

March 13, 2017

 

VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C.  20549

 

Re:                             Editas Medicine, Inc.

Registration Statement on Form S-3

File No. 333-216444

Request for Acceleration

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Editas Medicine, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-216444), as amended (the “Registration Statement”), so that it may become effective at 4:00 p.m. eastern time on March 15, 2017, or as soon thereafter as practicable.

 

 

Very truly yours,

 

 

 

 

 

 

 

Editas Medicine, Inc.

 

 

 

 

 

 

 

By:

/s/ Katrine S. Bosley

 

 

Katrine S. Bosley

 

 

Chief Executive Officer